These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 8223763)

  • 21. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
    Luedtke SA; Kuhn RJ; McCaffrey FM
    Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug therapy of tachycardial heart-rhythm disorders].
    Klein W
    Wien Med Wochenschr; 1976 Jun; 126(24):345-6. PubMed ID: 59469
    [No Abstract]   [Full Text] [Related]  

  • 23. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
    van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
    Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug therapy in supraventricular arrhythmia].
    Follath F; Candinas R; Meyer B
    Schweiz Rundsch Med Prax; 1992 Apr; 81(18):579-81. PubMed ID: 1594845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Tachycardias: considerations in childhood in the 90s].
    Gutiérrez-Larraya F; Jabón A
    An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
    [No Abstract]   [Full Text] [Related]  

  • 26. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.
    Gillis AM; Verma A; Talajic M; Nattel S; Dorian P;
    Can J Cardiol; 2011; 27(1):47-59. PubMed ID: 21329862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P; Frank R; Fontaine G; Tonet J; Tageddine R; Benassar A; Turlure A; Jacquemin M; Laborde JP
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1869-74. PubMed ID: 8729368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiarrhythmic drug therapy of ventricular arrhythmias.
    Huang SK; Marcus FI
    Curr Probl Cardiol; 1986 Apr; 11(4):177-240. PubMed ID: 3086035
    [No Abstract]   [Full Text] [Related]  

  • 31. Limitations to antiarrhythmic drug use in patients with atrial fibrillation.
    Humphries KH; Kerr CR; Steinbuch M; Dorian P;
    CMAJ; 2004 Sep; 171(7):741-5. PubMed ID: 15451836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current treatment of supraventricular tachycardia: drug therapy].
    Manz M; Lüderitz B
    Z Gesamte Inn Med; 1993 Sep; 48(9):430-8. PubMed ID: 8212748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
    Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia.
    Hamer AW; Strathmore N; Vohra JK; Hunt VD
    Pacing Clin Electrophysiol; 1993 Jul; 16(7 Pt 1):1394-400. PubMed ID: 7689205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of supraventricular tachyarrhythmias.
    Aronow WS
    Compr Ther; 1989 Apr; 15(4):11-6. PubMed ID: 2650980
    [No Abstract]   [Full Text] [Related]  

  • 36. [Rational bases for the therapy of supraventricular tachycardias and their management].
    Rostagno C; Bertini G; Padeletti L; Michelucci A; Del Pace S; Gensini GF
    Ann Ital Med Int; 1993; 8(4):235-43. PubMed ID: 8161480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
    Coumel P; Leclercq JF; Assayag P
    Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
    Patten M; Koch HP; Sonntag F; Lüderitz B; Meinertz T
    Z Kardiol; 1999 Mar; 88(3):185-94. PubMed ID: 10355069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of propafenone in emergency therapy].
    Liguori A; Pellegrino G; Di Ieso N; Piatto A; Ruggiero P; Scarnera P; Guardascione A
    Clin Ter; 1989 Dec; 131(5):307-14. PubMed ID: 2532584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flecainide acetate treatment of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation: dose-response studies. The Flecainide Supraventricular Tachycardia Study Group.
    Pritchett EL; DaTorre SD; Platt ML; McCarville SE; Hougham AJ
    J Am Coll Cardiol; 1991 Feb; 17(2):297-303. PubMed ID: 1899432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.